Rate and Predictive Factors of Rebleeding with Obscure-Overt Gastrointestinal Bleeding.
- Author:
Jong Hyung KIM
1
;
Young Ho KIM
;
Sun Young LEE
;
Hyun Wook JUNG
;
Jun Haeng LEE
;
Hee Jung SON
;
Poong Lyul RHEE
;
Jae J KIM
;
Jong Chul RHEE
Author Information
1. Department of Medicine, Sungkyunkwan University School of Medicine, Seoul, Korea. bowelkim@smc.samsung.co.kr
- Publication Type:Original Article
- Keywords:
Gastrointestinal bleeding;
Recurrence;
Risk factors;
Causes
- MeSH:
Adult;
Aged;
Angiodysplasia/complications/diagnosis;
Female;
Gastrointestinal Hemorrhage/diagnosis/*etiology;
Gastrointestinal Neoplasms/complications/diagnosis;
Humans;
Intestinal Diseases/complications/diagnosis;
Male;
Middle Aged;
Recurrence;
Risk Factors
- From:The Korean Journal of Gastroenterology
2004;44(1):19-24
- CountryRepublic of Korea
- Language:English
-
Abstract:
BACKGROUND/AIMS: Little information is available on the rate and predictive factors of rebleeding of unknown cause, which is very important in deciding further investigations on obscure-overt gastrointestinal bleeding. The aim of this study was to evaluate the rebleeding rate and related factors in obscure-overt gastrointestinal bleeding patients who revealed normal gastroscopic and colonoscopic findings. METHODS: A total of 69 patients with negative first-line gastroscopy and colonoscopy were enrolled in this study as obscure-overt gastrointestinal bleeding cases. The relationships between rebleeding and clinical characteristics were analyzed retrospectively. RESULTS: The causes of obscure-overt gastrointestinal bleeding were confirmed in 30 cases among the 69 cases. Small bowel tumors (14 cases) were the most common cause, followed by vascular lesions (6 cases). The mean follow-up period was 28 months and rebleeding was noticed in 19 patients (27.5%). Among these rebleeding patients, 14 cases (73.7%) occurred within 6 months. The past experience of previous bleeding was significantly related with rebleeding (p=0.0009). CONCLUSIONS: Close observation and detailed investigations are needed for obscure-overt gastrointestinal bleeding patients with bleeding history, especially during 6 months follow-up.
